Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS (full - 2003) http://www.pnas.org/content/100/18/10529.full
Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors (full – 2003)http://journals.lww.com/anesthesiolo...sia_by.31.aspx
New Compound That Acts On Peripheral Receptors May Be Promising Treatment For Some Nerve Pain (news - 2003)http://www.sciencedaily.com/releases...0812073750.htm
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids (full - 2005)http://www.pnas.org/content/102/8/3093.full
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain (abst - 2005)http://www.ncbi.nlm.nih.gov/pubmed/16316653
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? (full - 2006)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis (abst - 2006) http://www.ncbi.nlm.nih.gov/pubmed/16781706
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Peripheral Cannabinoids Attenuate Carcinoma Induced Nociception in Mice (full - 2008)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771220/
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full – 2008) http://jpet.aspetjournals.org/conten...#content-block
The endocannabinoid system in amyotrophic lateral sclerosis (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18781981
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis (full - 2009)http://onlinelibrary.wiley.com/doi/1...ibd.20960/full
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
Cannabinoids attenuate cancer pain and proliferation in a mouse model (full - 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...ihms285774.pdf
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system. (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22074629
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst – 2011)http://www.unboundmedicine.com/medli...inflamed_mice_
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...3/?tool=pubmed
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems (full – 2012)http://jpet.aspetjournals.org/content/340/3/629.full
Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012)http://rstb.royalsocietypublishing.o...f-857201f5e069
Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493696/
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Diuretic effects of cannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23296044
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24008428
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24148086
Diuretic effects of cannabinoid agonists in mice (abst – 2013) http://www.sciencedirect.com/science...14299913007176
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014)http://www.thejournalofheadacheandpa...2377-15-14.pdf
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart (link to PDF – 2014) http://life.scichina.com:8082/sciCe/...t513395.shtml#
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24866555
Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors (full – 2003)http://journals.lww.com/anesthesiolo...sia_by.31.aspx
New Compound That Acts On Peripheral Receptors May Be Promising Treatment For Some Nerve Pain (news - 2003)http://www.sciencedaily.com/releases...0812073750.htm
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids (full - 2005)http://www.pnas.org/content/102/8/3093.full
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain (abst - 2005)http://www.ncbi.nlm.nih.gov/pubmed/16316653
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? (full - 2006)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis (abst - 2006) http://www.ncbi.nlm.nih.gov/pubmed/16781706
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Peripheral Cannabinoids Attenuate Carcinoma Induced Nociception in Mice (full - 2008)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771220/
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full – 2008) http://jpet.aspetjournals.org/conten...#content-block
The endocannabinoid system in amyotrophic lateral sclerosis (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18781981
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis (full - 2009)http://onlinelibrary.wiley.com/doi/1...ibd.20960/full
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
Cannabinoids attenuate cancer pain and proliferation in a mouse model (full - 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/arti...ihms285774.pdf
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system. (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22074629
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst – 2011)http://www.unboundmedicine.com/medli...inflamed_mice_
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...3/?tool=pubmed
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems (full – 2012)http://jpet.aspetjournals.org/content/340/3/629.full
Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012)http://rstb.royalsocietypublishing.o...f-857201f5e069
Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493696/
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Diuretic effects of cannabinoids (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533417/
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23296044
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24008428
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24148086
Diuretic effects of cannabinoid agonists in mice (abst – 2013) http://www.sciencedirect.com/science...14299913007176
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014)http://www.thejournalofheadacheandpa...2377-15-14.pdf
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart (link to PDF – 2014) http://life.scichina.com:8082/sciCe/...t513395.shtml#
Terpenes and Lipids of the Endocannabinoid and Transient Receptor Potential-channel Biosignaling Systems (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24866555